BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 22687753)

  • 1. SPARC promotes the development of erythroid progenitors.
    Luo Z; Luo P; Yu Y; Zhao Q; Zhao X; Cheng L
    Exp Hematol; 2012 Oct; 40(10):828-36. PubMed ID: 22687753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric analysis of human bone marrow perfusion cultures: erythroid development and relationship with burst-forming units-erythroid.
    Rogers CE; Bradley MS; Palsson BO; Koller MR
    Exp Hematol; 1996 Apr; 24(5):597-604. PubMed ID: 8605964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
    Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
    Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human interleukin (IL)-9 specifically stimulates proliferation of CD34+++DR+CD33- erythroid progenitors in normal human bone marrow in the absence of serum.
    Lu L; Leemhuis T; Srour EF; Yang YC
    Exp Hematol; 1992 May; 20(4):418-24. PubMed ID: 1373687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common deleted genes in the 5q- syndrome: thrombocytopenia and reduced erythroid colony formation in SPARC null mice.
    Lehmann S; O'Kelly J; Raynaud S; Funk SE; Sage EH; Koeffler HP
    Leukemia; 2007 Sep; 21(9):1931-6. PubMed ID: 17625608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of HIV-related chemokine receptors and chemokines in human erythropoiesis in vitro.
    Majka M; Ratajczak J; Lee B; Honczarenko M; Douglas R; Kowalska MA; Silberstein L; Gewirtz AM; Ratajczak MZ
    Stem Cells; 2000; 18(2):128-38. PubMed ID: 10742385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe hypoxia enhances the formation of erythroid bursts from human cord blood cells and the maintenance of BFU-E in vitro.
    Cipolleschi MG; D'Ippolito G; Bernabei PA; Caporale R; Nannini R; Mariani M; Fabbiani M; Rossi-Ferrini P; Olivotto M; Dello Sbarba P
    Exp Hematol; 1997 Oct; 25(11):1187-94. PubMed ID: 9328456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic repopulating ability of cord blood CD34(+) cells in NOD/Shi-scid mice.
    Ueda T; Yoshino H; Kobayashi K; Kawahata M; Ebihara Y; Ito M; Asano S; Nakahata T; Tsuji K
    Stem Cells; 2000; 18(3):204-13. PubMed ID: 10840074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional Analysis of Erythroid Progenitors by Colony-Forming Assays.
    Palis J; Koniski A
    Methods Mol Biol; 2018; 1698():117-132. PubMed ID: 29076087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the coexpression of CD38, CD33 and HLA-DR antigens on CD34+ purified cells from human cord blood and bone marrow.
    De Bruyn C; Delforge A; Bron D; Bernier M; Massy M; Ley P; de Hemptinne D; Stryckmans P
    Stem Cells; 1995 May; 13(3):281-8. PubMed ID: 7613494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating CFU-E during hematopoietic recovery after allogeneic bone marrow transplantation: relationship to erythroid engraftment.
    Vannucchi AM; Bosi A; Lombardini L; Grossi A; Bacci P; Guidi S; Saccardi R; Rossi-Ferrini P
    Exp Hematol; 1995 Dec; 23(13):1337-40. PubMed ID: 7498360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transitional change of colony stimulating factor requirements for erythroid progenitors.
    Sawada K; Krantz SB; Dai CH; Sato N; Ieko M; Sakurama S; Yasukouchi T; Nakagawa S
    J Cell Physiol; 1991 Oct; 149(1):1-8. PubMed ID: 1719002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A hanging drop culture method to study terminal erythroid differentiation.
    Gutiérrez L; Lindeboom F; Ferreira R; Drissen R; Grosveld F; Whyatt D; Philipsen S
    Exp Hematol; 2005 Oct; 33(10):1083-91. PubMed ID: 16219530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ineffective erythropoiesis in mutant mice with deficient pyruvate kinase activity.
    Aizawa S; Harada T; Kanbe E; Tsuboi I; Aisaki K; Fujii H; Kanno H
    Exp Hematol; 2005 Nov; 33(11):1292-8. PubMed ID: 16263413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence in vitro of IL-3/Epo fusion proteins compared with the combination of IL-3 plus Epo in enhancing the proliferation of single isolated erythroid and multipotential progenitor cells from human umbilical cord blood and adult bone marrow.
    Lu L; Xiao M; Li ZH; Jolliffe LK; Jones S; Broxmeyer HE; Weich N
    Exp Hematol; 1995 Sep; 23(10):1130-4. PubMed ID: 7656932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and transcriptome analyses of human erythroid progenitors: BFU-E and CFU-E.
    Li J; Hale J; Bhagia P; Xue F; Chen L; Jaffray J; Yan H; Lane J; Gallagher PG; Mohandas N; Liu J; An X
    Blood; 2014 Dec; 124(24):3636-45. PubMed ID: 25339359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An improved serum free system for cloning human "pure" erythroid colonies. The role of different growth factors and cytokines on BFU-E formation by the bone marrow and cord blood CD34+ cells.
    Ratajczak J; Marlicz W; Machaliński B; Pertusini E; Czajka R; Ratajczak MZ
    Folia Histochem Cytobiol; 1998; 36(2):55-60. PubMed ID: 9606618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells.
    Traycoff CM; Abboud MR; Laver J; Brandt JE; Hoffman R; Law P; Ishizawa L; Srour EF
    Exp Hematol; 1994 Feb; 22(2):215-22. PubMed ID: 7507862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromal cell-mediated inhibition of erythropoiesis can be attenuated by Sotatercept (ACE-011), an activin receptor type II ligand trap.
    Iancu-Rubin C; Mosoyan G; Wang J; Kraus T; Sung V; Hoffman R
    Exp Hematol; 2013 Feb; 41(2):155-166.e17. PubMed ID: 23261964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.